EORTC-NCI-AACR--14th Symposium. Molecular targets and cancer therapeutics--part II. 19-22 November 2002, Frankfurt, Germany.
Patterson
Clare
C
Thomson Current Drugs, Middlesex House, 34-42 Cleveland Street, London W1T 4LB, UK. clare.patterson@current-drugs.com
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors; D051231:Farnesyltranstransferase; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines / Q000037:antagonists & inhibitors; D061965:Matrix Metalloproteinase Inhibitors; D014784:Mistletoe / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D037121:Plant Lectins / Q000627:therapeutic use; D019098:Telomerase / Q000037:antagonists & inhibitors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D061965:Matrix Metalloproteinase Inhibitors; D037121:Plant Lectins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D019883:Alkyl and Aryl Transferases; D051231:Farnesyltranstransferase; D019098:Telomerase